Log in

Relevant bibliographies by topics / Estrogen Receptor - Cancer Therapeutics / Books

Books on the topic 'Estrogen Receptor - Cancer Therapeutics'

To see the other types of publications on this topic, follow the link: Estrogen Receptor - Cancer Therapeutics.

Author: Grafiati

Published: 7 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 20 books for your research on the topic 'Estrogen Receptor - Cancer Therapeutics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Craig, Jordan V., and Furr B. J. A, eds. Hormone therapy in breast and prostate cancer. Totowa, N.J: Humana Press, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

1944-, Miller William R., and Ingle James N. 1944-, eds. Endocrine therapy in breast cancer. New York: Marcel Dekker, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhang, Xiaoting, ed. Estrogen Receptor and Breast Cancer. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99350-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Power, Krista Anne. Selective estrogen receptor modulators in breast cancer. Ottawa: National Library of Canada, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

M, Berstein Lev, and Santen Richard J, eds. Innovative endocrinology of cancer. New York: Springer Science+Business Media, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Moelleken, Brent Roderick Wilfred. Tamoxifen - 5-fluorouracil synergy in human breast cancer cell lines: Correlating in vitro synergy with the current estrogen receptor model. [New Haven: s.n.], 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Yarden, Yosef, and Moshe Elkabets, eds. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67932-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

MIller/Ingle. Endocrine Therapy in Breast Cancer. Informa Healthcare, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

(Editor), James N. Ingle, and Mitchell Dowsett (Editor), eds. Endocrine Therapy for Breast Cancer. Informa Healthcare, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Estrogen/antiestrogen action and breast cancer therapy. Madison, Wis: University of Wisconsin Press, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Estrogen Antiestrogen Action and Breast Cancer Therapy. University of Wisconsin Press, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Zhang, Xiaoting. Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER. Springer International Publishing AG, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER. Humana, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Santen, Richard J., and Lev M. Berstein. Innovative Endocrinology of Cancer. Springer London, Limited, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Santen, Richard J., Lev M. Berstein, and various. Innovative Endocrinology of Cancer. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Yarden, Yosef, and Moshe Elkabets. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Yarden, Yosef, and Moshe Elkabets. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Springer, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Estrogens, Estrogen Receptor, and Breast Cancer (Biomedical and Health Research, Vol. 36) (BIOMEDICAL AND HEALTH RESEARCH SERIES). I O S PRESS, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Watson, Estelle. Molecular modelling of the human estrogen receptor and investigation of the activity of oestrogenic compounds in breast cancer cell lines. 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tamimi, Rulla, Susan Hankinson, and Pagona Lagiou. Breast Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0016.

Full text

Abstract:

Most of the established reproductive risk factors for breast cancer, like age at menarche or parity, are not appropriate for public health intervention. Several lines of evidence, like the associations with birthweight and early exposure to radiation, support an important influence of early-life events on subsequent breast cancer risk. The best established modifiable risk factors for the disease include postmenopausal hormone use, moderate alcohol intake, and adult weight gain. More recently, we have come to appreciate that instead of a single disease, breast cancer is rather a heterogeneous group of subtypes with different etiologies. Yet the wealth of available epidemiologic information can be synthesized into a consistent and testable, albeit still hypothetical, causal model. With our increasing knowledge on the relation between endogenous hormones and breast cancer, and the development of selective estrogen receptor modulators, as well as aromatase inhibitors, chemoprevention will likely become more common in the future.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!